rho GTPase Activating Protein 36 (ARHGAP36) (N-Term) Peptide
ARHGAP36
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all ARHGAP36 products
- ARHGAP36 (rho GTPase Activating Protein 36 (ARHGAP36))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- KPDRALPIDR PNTLDKWFLI LRGQQRAVSH KTFGISLEEV LVNEFTRRKH
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-RP13-102H20.1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- ARHGAP36 (rho GTPase Activating Protein 36 (ARHGAP36))
- Background
-
RP13-102H20.1 is the GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state.
Alias Symbols: FLJ30058
Protein Size: 547 - Molecular Weight
- 62 kDa
- Gene ID
- 158763
- NCBI Accession
- NM_144967, NP_659404
- UniProt
- Q6ZRI8
-
You are here:
